Morgan Schmincke, MS, CCC-SLP | |
2644 Riva Rd, Annapolis, MD 21401-7427 | |
(410) 222-5000 | |
Not Available |
Full Name | Morgan Schmincke |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 2644 Riva Rd, Annapolis, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417428202 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Morgan Schmincke, MS, CCC-SLP 1206 Farley Ct N, Arnold, MD 21012-2813 Ph: () - | Morgan Schmincke, MS, CCC-SLP 2644 Riva Rd, Annapolis, MD 21401-7427 Ph: (410) 222-5000 |
News Archive
A new study shows that the COVID-19 infection incidence has been low in people with rheumatic diseases, and most of those infected experience a mild course of illness.
Stroke treatments and prevention to improve quality of life for people who experience a stroke is poorer than researchers hoped, with stroke still taking nearly three out of five quality years off a person's life, according to a new study published in the October 9, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.
Starting in 2013 Maney will be collaborating with the Asia Pacific Society for the Study of Speech, Language and Hearing (APSSLH) to launch Speech, Language and Hearing. This is a significant development for both Maney and the Society.
Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrel - a drug that prevents blood clots - were only half as likely to be hospitalized for upper digestive tract bleeding than those who used clopidogrel alone, according to a new study supported by HHS' Agency for Healthcare Research and Quality and the National Heart, Lung, and Blood Institute at the National Institutes of Health.
Single reading events of a signaling molecule at a given time should no longer be considered as the only insightful indicator to predict the usefulness of a new drug candidate.
› Verified 3 days ago
Fran L Silverman, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 | |
Anne Caverly, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 | |
Taylor Falatach, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 Williams Dr, Annapolis, MD 21401 Phone: 609-519-1954 | |
Mrs. Betty Chan-brown, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 190 Admiral Cochrane Dr, Suite 180, Annapolis, MD 21401 Phone: 410-571-6411 Fax: 410-571-6415 | |
Mrs. Judith Ann Wildner, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 | |
Rajavi Sanghavi, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 900 Van Buren St, Annapolis, MD 21403 Phone: 410-267-8653 Fax: 877-828-2060 | |
Victoria Washington-harper, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 |